Company / Free Cash Flow
PULSE BIOSCIENCES, INC. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$54.4M
FY2025
5-year range
-$54.5M / -$36.5M
FY2021-FY2025
Trend
-49.3%
vs FY2024
Sector context
#132 of 151
Health Care
What the data says
PULSE BIOSCIENCES, INC.'s free cash flow of -$54M is lower than 87% of companies in the Health Care sector (FY2025). Declined from -$47M to -$54M over the past 2 years.
Based on SEC 10-K filings.
-$54M in FY2025.
Declined from -$47M to -$54M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 151This company -$54.4M Sector average $779.8M
▼
-107.0% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 49.3% year-over-year.
- Ranks #132 out of 151 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2016.
- Lowest free cash flow in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$54.4M | -49.3% |
| FY2024 | -$36.5M | +23.1% |
| FY2023 | -$47.4M | +0.0% |
| FY2022 | -$47.4M | +13.1% |
| FY2021 | -$54.5M | -52.3% |
| FY2020 | -$35.8M | -2.9% |
| FY2019 | -$34.8M | -43.9% |
| FY2018 | -$24.2M | -77.2% |
| FY2017 | -$13.6M | -68.1% |
| FY2016 | -$8.1M | -138.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026